Immunofluorescent analysis of A549 cells treated with TGFβ, using Phospho-Smad3 (S423 + S425) Antibody.
Immunofluorescent analysis of A549 cells treated with TGFβ, using Phospho-Smad3 (S423 + S425) Antibody.
Anti-Phospho-Smad3 (S423 + S425) Rabbit Monoclonal Antibody
P00059-1
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman, Mouse
TargetSMAD3
Overview
- SupplierBoster Bio
- Product NameAnti-Phospho-Smad3 (S423 + S425) Rabbit Monoclonal Antibody
- Delivery Days Customer9
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDAHO-19
- FormulationLiquid
- Gene ID4088
- Target nameSMAD3
- Target descriptionSMAD family member 3
- Target synonymshMAD-3; hSMAD3; HSPC193; HsT17436; JV15-2; LDS1C; LDS3; MAD homolog 3; mad homolog JV15-2; mad protein homolog; MAD, mothers against decapentaplegic homolog 3; mad3; MADH3; mothers against decapentaplegic homolog 3; mothers against DPP homolog 3; SMA- and MAD-related protein 3; SMAD, mothers against DPP homolog 3
- HostRabbit
- IsotypeIgG
- Modification TypePhosphorylated
- Protein IDP84022
- Protein NameMothers against decapentaplegic homolog 3
- Scientific DescriptionBoster Bio Anti-Phospho-Smad3 (S423 + S425) Rabbit Monoclonal Antibody catalog # P00059-1. Tested in WB, IHC, ICC/IF applications. This antibody reacts with Human, Mouse.
- ReactivityHuman, Mouse
- Storage Instruction-20°C
- UNSPSC12352203
References
- Local administration of liposomal-based Srpx2 gene therapy reverses pulmonary fibrosis by blockading fibroblast-to-myofibroblast transition. Wang Q et al., 2021, TheranosticsRead more